All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
January 27, 2024 January 26, 2024 – Company announcement no. 1 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038 [email protected] Press RelationsSanne Seyer-Hansen+45 6038 [email protected]
Attachment
No. 1 All necessary regulatory approvals have been obtained